Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Net Income towards Common Stockholders: 2016-2021

Historic Net Income towards Common Stockholders for ENDRA Life Sciences (NDRA) over the last 6 years, with Dec 2021 value amounting to -$3.1 million.

  • ENDRA Life Sciences' Net Income towards Common Stockholders fell 37.94% to -$3.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$11.4 million, marking a year-over-year increase of 6.34%. This contributed to the annual value of -$11.5 million for FY2024, which is 14.39% down from last year.
  • ENDRA Life Sciences' Net Income towards Common Stockholders amounted to -$3.1 million in Q4 2021, which was down 16.79% from -$2.7 million recorded in Q3 2021.
  • In the past 5 years, ENDRA Life Sciences' Net Income towards Common Stockholders ranged from a high of -$741,623 in Q1 2017 and a low of -$9.0 million during Q4 2019.
  • For the 3-year period, ENDRA Life Sciences' Net Income towards Common Stockholders averaged around -$3.4 million, with its median value being -$3.0 million (2020).
  • Per our database at Business Quant, ENDRA Life Sciences' Net Income towards Common Stockholders plummeted by 281.68% in 2019 and then skyrocketed by 75.07% in 2020.
  • Quarterly analysis of 5 years shows ENDRA Life Sciences' Net Income towards Common Stockholders stood at -$2.3 million in 2017, then fell by 3.09% to -$2.4 million in 2018, then slumped by 281.68% to -$9.0 million in 2019, then skyrocketed by 75.07% to -$2.3 million in 2020, then tumbled by 37.94% to -$3.1 million in 2021.
  • Its Net Income towards Common Stockholders stands at -$3.1 million for Q4 2021, versus -$2.7 million for Q3 2021 and -$3.2 million for Q2 2021.